Dorton, Davis Added to Sonoma Biotherapeutics B of Directors

Atomwise Signs Multi-Target Research Collaboration with Sanofi

Genexine doses first patient in phase 2 clinical trial using triple combination therapy in patients with head and neck squamous cell carcinoma

WuXi STA announces ground-breaking for new in Delaware pharmaceutical manufacturing campus

Pneumagen doses first participant in Neumifil phase two controlled human infection challenge study

South Rampart Pharma names new chief financial officer

BeiGene Forms Strategic Alliance with Ontada to Improve US Community Oncology Care

Enhertu Significantly Delayed Disease Progression in DESTINY-Breast02 Phase 3 Trial Versus Physician's Choice of Treatment in Patients with HER2 Positive Metastatic Breast Cancer

AstraZeneca reports Lynparza granted FDA Priority Review

GSK completes Affinivax acquisition

Gannex Pharma doses first participant in DDI study of ASC42 to treat primary biliary cholangitis

Daewoong Pharmaceutical's DWP213388 receives US FDA clinical trial approval

Q32 Bio and Horizon Therapeutics sign collaboration and option agreement to produce ADX-914

Anixa Biosciences treats first patient in CAR-T therapy ovarian cancer clinical trial in collaboration with Moffitt Cancer Center

Verogen and Gene by Gene form Partnership to Accelerate Adoption of Forensic Investigative Genetic Genealogy